Tower Research Capital (TRC)’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3K | Buy |
1,483
+428
| +41% | +$3.84K | ﹤0.01% | 3867 |
|
|
2025
Q1 | $6.66K | Buy |
1,055
+259
| +33% | +$1.64K | ﹤0.01% | 4024 |
|
|
2024
Q4 | $8.2K | Buy |
796
+494
| +164% | +$5.09K | ﹤0.01% | 4013 |
|
|
2024
Q3 | $3.89K | Buy |
302
+166
| +122% | +$2.14K | ﹤0.01% | 4745 |
|
|
2024
Q2 | $1.89K | Sell |
136
-42
| -24% | -$584 | ﹤0.01% | 5080 |
|
|
2024
Q1 | $55.5K | Buy |
178
+131
| +279% | +$40.8K | ﹤0.01% | 2206 |
|
|
2023
Q4 | $12.4K | Sell |
47
-88
| -65% | -$23.2K | ﹤0.01% | 4046 |
|
|
2023
Q3 | $26.4K | Buy |
135
+106
| +366% | +$20.8K | ﹤0.01% | 3123 |
|
|
2023
Q2 | $5.93K | Sell |
29
-170
| -85% | -$34.7K | ﹤0.01% | 4746 |
|
|
2023
Q1 | $20K | Buy |
199
+103
| +107% | +$10.4K | ﹤0.01% | 3429 |
|
|
2022
Q4 | $15K | Buy |
96
+26
| +37% | +$4.06K | ﹤0.01% | 3432 |
|
|
2022
Q3 | $17K | Buy |
70
+52
| +289% | +$12.6K | ﹤0.01% | 4072 |
|
|
2022
Q2 | $5K | Buy |
+18
| New | +$5K | ﹤0.01% | 5073 |
|
|
2022
Q1 | – | Sell |
-213
| Closed | -$47K | – | 6365 |
|
|
2021
Q4 | $47K | Buy |
213
+128
| +151% | +$28.2K | ﹤0.01% | 2813 |
|
|
2021
Q3 | $38K | Buy |
85
+57
| +204% | +$25.5K | ﹤0.01% | 3178 |
|
|
2021
Q2 | $11K | Buy |
28
+7
| +33% | +$2.75K | ﹤0.01% | 4327 |
|
|
2021
Q1 | $13K | Sell |
21
-17
| -45% | -$10.5K | ﹤0.01% | 4205 |
|
|
2020
Q4 | $21K | Sell |
38
-44
| -54% | -$24.3K | ﹤0.01% | 3838 |
|
|
2020
Q3 | $46K | Buy |
82
+66
| +413% | +$37K | ﹤0.01% | 3571 |
|
|
2020
Q2 | $9K | Buy |
+16
| New | +$9K | ﹤0.01% | 4058 |
|